Diabetes Research and Clinical Practice
Volume 72, Issue 1 , Pages 33-41 , April 2006

Effect of fast-food Mediterranean-type diet on type 2 diabetics and healthy human subjects’ platelet aggregation

  • Haralabos C. Karantonis

      Affiliations

    • National and Kapodistrian University of Athens, Faculty of Chemistry, Panepistimioupolis, 15771 Athens, Greece
    • ,
  • Elizabeth Fragopoulou

      Affiliations

    • National and Kapodistrian University of Athens, Faculty of Chemistry, Panepistimioupolis, 15771 Athens, Greece
    • ,
  • Smaragdi Antonopoulou

      Affiliations

    • Harokopio University of Athens, Department of Science of Nutrition-Dietetics, 17671 Athens, Greece
    • ,
  • John Rementzis

      Affiliations

    • National and Kapodistrian University of Athens, Faculty of Chemistry, Panepistimioupolis, 15771 Athens, Greece
    • ,
  • Costas Phenekos

      Affiliations

    • Red Cross Hospital, Department of Endocrinology and Metabolism, 11526 Athens, Greece
    • ,
  • Constantinos A. Demopoulos

      Affiliations

    • National and Kapodistrian University of Athens, Faculty of Chemistry, Panepistimioupolis, 15771 Athens, Greece
    • Corresponding Author InformationCorresponding author at: 39 Anafis Street, Athens GR-113 64, Greece. Tel.: +30 210 7274265; fax: +30 210 7274265.

Received 6 October 2004 ,Revised 3 May 2005 ,Accepted 6 September 2005.

References 

  1. Gopaul NK, Zacharowski K, Halliwell B, Anggard EE. Evaluation of the postprandial effects of a fast-food meal on human plasma F(2)-isoprostane levels. Free Radic. Biol. Med. 2000;28:806–814
  2. Diehl JM. Food preferences of 10- to 14-year-old boys and girls. Schweiz. Med. Wochenschr. 1999;129:151–161
  3. Burklow J, Aubertin A. Fast food chains move towards healthier choices. J. Natl. Cancer Inst. 1991;83:325–326
  4. Keys A, Menotti A, Karvonen MJ. The diet and 15-year death rate in the seven countries study. Am. J. Epidemiol. 1986;124:903–915
  5. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis, epidemiology, pathophysiology, and management. JAMA. 2002;287:2570–2581
  6. Semenkovich CF, Heinecke JW. The mystery of diabetes and atherosclerosis: time for a new plot. Diabetes. 1997;46:327–334
  7. Bierman EL. George Lyman Duff memorial lecture. Atherogenesis in diabetes. Arterioscler. Thromb. 1992;12:647–656
  8. McManus LM, Hanahan DJ, Pinckard RN. Human platelet stimulation by acetyl glyceryl ether phosphorylcholine. J. Clin. Invest. 1981;67:903–906
  9. Golino P, Ambrosio G, Ragni M. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation. Circulation. 1993;88:1205–1214
  10. Klinger MH. Platelets and inflammation. Anat. Embryol. (Berl). 1997;196:1–11
  11. Pabla R, Weyrich AS, Dixon DA. Integrin-dependent control of translation: engagement of integrin alphaIIbbeta3 regulates synthesis of proteins in activated human platelets. J. Cell Biol. 1999;144:175–184
  12. Demopoulos CA, Pinckard RN, Hanahan DJ. Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J. Biol. Chem. 1979;254:9355–9358
  13. Prescott SM, Zimmerman GA, Stafforini DM, McIntyre TM. Platelet-activating factor and related lipid mediators. Annu. Rev. Biochem. 2000;69:419–445
  14. Patel KD, Zimmerman GA, Prescott SM, McEver RP, McIntyre TM. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J. Cell Biol. 1991;112:749–759
  15. Krull M, Dold C, Hippenstiel S, Rosseau S, Lohmeyer J, Suttorp N. Escherichia coli hemolysin and Staphylococcus aureas alpha-toxin potently induce neutrophil adhesion to cultured human endothelial cells. J. Immunol. 1996;157:4133–4140
  16. Bunting M, Lorant DE, Bryant AE. Alpha toxin from Clostridium perfringens induces proinflammatory changes in endothelial cells. J. Clin. Invest. 1997;100:565–574
  17. Nagase T, Ishii S, Kume K. Platelet-activating factor mediates acid-induced lung injury in genetically engineered mice. J. Clin. Invest. 1999;104:1071–1076
  18. Zhou W, Javors MA, Olson MS. Platelet-activating factor as an intercellular signal in neutrophil-dependent platelet activation. J. Immunol. 1992;149:1763–1769
  19. Ninio E, Leyravaud S, Bidault J, Jurgens P, Benveniste J. Cell adhesion by membrane-bound PAF-acether. Int. Immunol. 1991;3:1157–1163
  20. Ostrovsky L, King AJ, Bond S. A juxtacrine mechanism for neutrophil adhesion on platelets involves platelet-activating factor and a selectin-dependent activation process. Blood. 1998;91:3028–3036
  21. Weber C, Springer TA. Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor. J. Clin. Invest. 1997;100:2085–2093
  22. Parthasarathy S, Santanam N, Ramachandran S, Meilhac O. Oxidants and antioxidants in atherogenesis. An appraisal. J. Lipid Res. 1999;40:2143–2157
  23. Liapikos TA, Antonopoulou S, Karabina SP, Tsoukatos DC, Demopoulos CA, Tselepis AD. Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated. Biochim. Biophys. Acta. 1994;1212:353–360
  24. Demopoulos CA, Karantonis HC, Antonopoulou S. Platelet activating factor – a molecular link between atherosclerosis theories. Eur. J. Lipid. Sci. Technol. 2003;105:705–716
  25. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 1959;37:911–917
  26. Galanos DS, Kapoulas VM. Isolation of polar lipids from triglyceride mixtures. J. Lipid Res. 1962;3:134–137
  27. A. Trichopoulou, Greek Food Composition Tables, 2nd ed., Litsas Publications, Athen, Greece, 1992.
  28. Antonopoulou S, Semidalas CE, Koussissis SG, Demopoulos CA. Platelet-activating factor (PAF) antagonists in foods. A study of lipids, with PAF or anti-PAF like-activity, in cow's milk and yoghurt. J. Agric. Food Chem. 1996;44:3047–3051
  29. Koussissis SG, Semidalas CE, Hadzistavrou EC, Kalyvas V, Antonopoulou S, Demopoulos CA. PAF antagonists in foods: isolation and identification of PAF in honey and wax. Rev. Fr. Corp. Gras. 1994;41:127–132
  30. Koussissis SG, Semidalas CE, Antonopoulou S, Kapoulas VM, Demopoulos CA, Kalyvas V. PAF antagonists in foods: isolation and identification of PAF in virgin olive oil. Rev. Fr. Corp. Gras. 1993;40:323–327
  31. Karantonis HC, Antonopoulou S, Demopoulos CA. Antithrombotic lipid minor constituents from vegetable oils. Comparison between olive oils and others. J. Agric. Food Chem. 2002;50:1150–1160
  32. Fragopoulou E, Nomikos T, Antonopoulou S, Mitsopoulou CA, Demopoulos CA. Separation of biologically active lipids from red wine. J. Agric. Food Chem. 2000;48:1234–1238
  33. Fragopoulou E, Nomikos T, Tsantila N, Mitropoulou A, Zabetakis I, Demopoulos CA. Biological activity of total lipids from red and white wine/must. J. Agric. Food Chem. 2001;49:5186–5193
  34. Fragopoulou E, Antonopoulou S, Demopoulos CA. Biologically active lipids with antiatherogenic properties from white wine and must. J. Agric. Food Chem. 2002;50:2684–2694
  35. Rementzis J, Antonopoulou S, Argyropoulos D, Demopoulos CA. Biologically active lipids from S. scombrus. Adv. Exp. Med. Biol. 1996;416:65–72
  36. Panayiotou A, Samartzis D, Nomikos T. Lipid fractions with aggregatory and antiaggregatory activity toward platelets in fresh and fried cod (Gadus morhua): correlation with platelet-activating factor and atherogenesis. J. Agric. Food Chem. 2000;48:6372–6379
  37. Leoncini G, Signorello MG, Piana A, Carrubba M, Armani U. Hyperactivity and increased hydrogen peroxide formation in platelets of NIDDM patients. Thromb. Res. 1997;86:153–160
  38. Jones DB, Davis TM, Bown E, Carter RD, Mann JI, Prescott RJ. Determinants of ADP-induced platelet aggregation in diabetes mellitus. Diabetologia. 1986;29:291–294
  39. Ferroni P, Basili S, Falco A, Davı G. Platelet activation in type 2 diabetes mellitus. J. Thromb. Haemost. 2004;2:1282–1291
  40. Sanders TA. Olive oil and the Mediterranean diet. Int. J. Vitam. Nutr. Res. 2001;71:179–184
  41. Daviglus ML, Stamler J, Orencia AJ. Fish consumption and the 30-year risk of fatal myocardial infarction. N. Engl. J. Med. 1997;336:1046–1053
  42. de Gaetano G, Cerletti C. Wine and cardiovascular disease. Nutr. Metab. Cardiovasc. Dis. 2001;11:47–50
  43. Weyrich AS, Prescott SM, Zimmerman GA. Platelets, endothelial cells, inflammatory chemokines, and restenosis: complex signaling in the vascular play book. Circulation. 2002;106:1433–1435
  44. Marathe GK, Zimmerman GA, Prescott SM, McIntyre TM. Activation of vascular cells by PAF-like lipids in oxidized LDL. Vascul. Pharmacol. 2002;38:193–200
  45. Zimmerman GA, McIntyre TM, Prescott SM, Stafforini DM. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit. Care Med. 2002;30:S294–S301
  46. Lorant DE, Zimmerman GA, McIntyre TM, Prescott SM. Platelet-activating factor mediates procoagulant activity on the surface of endothelial cells by promoting leukocyte adhesion. Semin. Cell Biol. 1995;6:295–303
  47. Mueller HW, Haught CA, McNatt JM. Measurement of platelet-activating factor in a canine model of coronary thrombosis and in endarterectomy samples from patients with advanced coronary artery disease. Circ. Res. 1995;77:54–63
  48. Feliste R, Perret B, Braquet P, Chap H. Protective effect of BN 52021, a specific antagonist of platelet-activating factor (PAF-acether) against diet-induced cholesteryl ester deposition in rabbit aorta. Atherosclerosis. 1989;78:151–158
  49. Subbanagounder G, Leitinger N, Shih PT, Faull KF, Berliner JA. Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis: in vitro and in vivo inhibition by WEB. Circ. Res. 1999;85:311–318

PII: S0168-8227(05)00359-1

doi: 10.1016/j.diabres.2005.09.003

Diabetes Research and Clinical Practice
Volume 72, Issue 1 , Pages 33-41 , April 2006

Article Tools